Ucwaningo olusha lwezokwelapha lwabantu lusebenzisa isithako se-ashwagandha esisezingeni eliphezulu, esinelungelo lobunikazi, i-Witholytin, ukuhlola imiphumela yaso emihle ekukhathaleni nasekucindezelekeni.
Abacwaningi bahlole ukuphepha kwe-ashwagandha kanye nomthelela wayo ekukhathaleni nasekucindezelekeni okubonwayo kwabesilisa nabesifazane abayi-111 abanempilo abaneminyaka engu-40-75 ababhekane namazinga aphansi amandla kanye nokucindezeleka okubonwayo okuphakathi kuya kokuphezulu esikhathini esingamasonto ayi-12. Ucwaningo lusebenzise umthamo we-ashwagandha ongu-200 mg kabili ngosuku.
Imiphumela ikhombisile ukuthi ababambiqhaza abathatha i-ashwagandha bathole ukwehla okukhulu okungu-45.81% kwamaphuzu omhlaba wonke e-Chalder Fatigue Scale (CFS) kanye nokwehla okungu-38.59% kokucindezeleka (isikali sokucindezeleka esibonwayo) uma kuqhathaniswa nesisekelo ngemuva kwamasonto ayi-12.
Eminye imiphumela ibonise ukuthi amaphuzu angokomzimba ku-Patient Reported Outcome Measurement Information System (PROMIS-29) akhuphuke (athuthukisiwe) ngo-11.41%, amaphuzu angokwengqondo ku-PROMIS-29 (athuthukisiwe) anciphe ngo-26.30% futhi akhuphuke ngo-9 .1% uma kuqhathaniswa ne-placebo. Ukwehluka kwesilinganiso senhliziyo (HRV) kwehle ngo-18.8%.
Isiphetho salolu cwaningo sibonisa ukuthi i-ashwagandha inamandla okusekela indlela yokuguquguquka, ukulwa nokukhathala, ukuvuselela umzimba, nokukhuthaza i-homeostasis kanye nebhalansi.
Abacwaningi abahilelekile kulolu cwaningo bathi i-ashwagandha inezinzuzo ezinkulu ezinika amandla kubantu abaseminyakeni ephakathi kanye nabadala abakhuluphele ababhekene namazinga aphezulu okucindezeleka nokukhathala.
Kwenziwe ukuhlaziywa okuncane ukuze kuhlolwe ama-biomarker ama-hormone kwabesilisa nabesifazane ababambe iqhaza. Amazinga egazi e-testosterone yamahhala (p = 0.048) kanye ne-luteinizing hormone (p = 0.002) akhushulwe kakhulu ngo-12.87% kwabesilisa abathatha i-ashwagandha uma kuqhathaniswa neqembu le-placebo.
Njengoba kunikezwe le miphumela, kubalulekile ukutadisha kabanzi amaqembu abantu angase azuze ngokuthatha i-ashwagandha, njengoba imiphumela yayo yokunciphisa ukucindezeleka ingahluka kuye ngezici ezifana nobudala, ubulili, isimo sesisindo somzimba, nezinye izinto eziguquguqukayo.
“Siyajabula ukuthi le ncwadi entsha ihlanganisa ubufakazi obusekela i-Vitolitin nobufakazi bethu obukhulayo obubonisa ukwenziwa kwe-USP kwe-ashwagandha extract,” kuchaza uSonya Cropper, iphini likamongameli omkhulu we-Verdure Sciences. UCropper uyaqhubeka, “Kukhona isithakazelo esikhulayo ku-ashwagandha, ama-adaptogens, ukukhathala, amandla kanye nokusebenza kwengqondo.”
I-Vitolitin ikhiqizwa yi-Verdure Sciences futhi isatshalaliswa eYurophu yi-LEHVOSS Nutrition, okuyisigaba se-LEHVOSS Group.